Modeling antiangiogenesis gene therapy

Cancer Biology and Therapy

Volumn 1, Issue 5, 2002, Pages 554-555

  Tsai, Jeff H ^a   Lee, William M F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN RECEPTOR 2;

ADENOVIRUS; ANIMAL; CELL LINE; CELL TRANSPLANTATION; DISEASE MODEL; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); NOTE; PROSTATE TUMOR; TRANSGENIC MOUSE; XENOGRAFT;

ADENOVIRIDAE; ANIMALS; CELL LINE; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MALE; MICE; MICE, SCID; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 1842858917     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.1.5.221     Document Type: Note

References (12)

1. Rak J, Yu JL, Klement G, et al. Oncogenes and angiogenesis: signaling three-dimensional tumor growth. J Invest Dermatol Symp Proc 2000; 5:24-34.
2. Greenberg NM, DeMayo F, Finegold MJ, et al. Postate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995; 92:3439-43.
3. MacGrogan D, Bookstein R. Tumor suppressor genes in prostate cancer. Semin Cancer Biol 1997; 8:11-9. (Pubitemid 27417425)
4. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125(9):1591-8. (Pubitemid 28256727)
5. Eberhard A, Kahlert S, Goede V, et al. Heterogeneity of Angiogenesis and Blood Vessel Maturation in Human Tumors: Implications for Antiangiogenic Tumor Therapies. Cancer Research 2000; 60:1388-93. (Pubitemid 30152012)
6. Gee MS, Lee WMF. (unpublished observations).
7. Kim I, Kim HG, So JN, et al. Angiopoietin-1 regulates endothelial cell survival through the phophatidylinositol 3′-kinase/AKT signal transduction pathway. Circ Res 2000; 86:24-9. (Pubitemid 30044164)
8. Papapetropoulos A, Fulton D, Mahboubi K, et al. Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathway. J Biol Chem 2000; 275:9102-5. (Pubitemid 30185122)
9. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 1996; 379:88-91. (Pubitemid 26008141)
10. Yu JL, Rak JW , Carmeliet P, et al. Heterogeneous vascular dependence of tumor cell populations. Am J Pathol 2001; 158:1325-34. (Pubitemid 32281296)
11. Yang Y, Nunes FA, Berencsi K, et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91:4407-11. (Pubitemid 24143442)
12. Kay MA, Manno CS, Ragni MV, et al. Evidence for gene transfer and expression of factor IX in hemophilia B patients treated with AAV vector. Nat Genet 2000; 24:257-61. (Pubitemid 30132193)